~~<i id='3CC4D58F5E'><strike id='3CC4D58F5E'><tt id='3CC4D58F5E'><pre id='3CC4D58F5E'></pre></tt></strike></i>~~

Home» knowledge» focus

focus

author：hotspot 2025-10-06 13:51:06 Page View：97369

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

knowledge

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

0:58FormerPresidentDonaldTrumppausesforcheersfromthecrowdbeforespeakingasthekeynotespeakeratthe56thA

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Why scientists need input from humanists on sensitive research

AdobeScientistsaretaughtearlyinourtrainingthatcriticismisafundamentalpartofthejob.Whatwearenotusuall

WSS

focus

focus

explore

knowledge

Why scientists need input from humanists on sensitive research